• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

mergers and acquisitions

liver
MedTech

Terumo inks $1.5B deal for liver transplant developer OrganOx

The deal would mark the Japanese devicemaker’s entry into organ transplants, with OrganOx’s platform providing tissue perfusion during transport.
Conor Hale Aug 25, 2025 11:45am
Brain and money connected by a thread on a white background

AbbVie inks $1.2B deal to buy Gilgamesh's psychedelic program

Aug 25, 2025 9:42am
Blood sample microscope study clinical trial lab research

Tempus claims AI pathology developer Paige in $81M deal

Aug 22, 2025 12:30pm
rainbow kite flying in the sky

Kite sails into in vivo CAR-T space via $350M Interius buyout

Aug 21, 2025 9:59am
Painting over a mural with blue paint

Painted into a corner, Mural agrees to Xoma buyout

Aug 20, 2025 10:28am
puzzle pieces merger and acquisition business concept

Private equity firm acquires site network Headlands Research

Aug 18, 2025 1:53pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings